83. アジソン病 Disease details / Clinical trials / Drug dev / DR info

臨床試験数 : 21 / 薬物数 : 29 - (DrugBank : 9) / 標的遺伝子数 : 6 - 標的パスウェイ数 : 18

薬物、開発者（Primary Sponsor）、臨床試験情報（症例登録開始年（Enrollment year）、フェーズ、ID、実施国）
30-hour ambulatory sampling OF intestinal fluid
   University of Bergen
      2018   -   NCT03793114   Germany;Norway;Sweden
Baseline blood tests
   University of Bergen
      2018   -   NCT03793114   Germany;Norway;Sweden
Betamethasone
   Göteborg University
      2021   Phase 4   NCT03210545   Sweden
Cortef 5 MG
   Haukeland University Hospital
      2013   Phase 2   EUCTR2013-004189-33-NO   Norway
Cosyntropin stimulation test
   University of Bergen
      2018   -   NCT03793114   Germany;Norway;Sweden
Dehydroepiandrosterone
   National Center for Research Resources (NCRR)
      1995   Phase 3   NCT00004313   -
Depot tetracosactide
   Newcastle University
      2010   Phase 4   NCT01371526   United Kingdom
Grapefruit juice
   Haukeland University Hospital
      2008   -   NCT01271296   Norway
Hydrocortison 100 MG (pfizer®) IN 2 ML solvent
   University Hospital of Wuerzburg
      2011   -   EUCTR2011-002687-25-DE   Germany
Hydrocortisone
   EM-kliniken
      2006   -   EUCTR2005-001768-30-SE   Sweden
   Haukeland University Hospital
      2013   Phase 2   NCT01847690   Norway
      2010   Phase 2/Phase 3   NCT01063569   Norway;Sweden
   Oregon Health and Science University
      2000   -   NCT00688987   United States
   Vastra Gotaland Region
      2014   -   NCT02152553   Sweden
Hydrocortisone 100MG/ML
   The London Clinic
      2022   Phase 4   NCT05350020   United Kingdom
      2015   Phase 4   EUCTR2015-001090-40-GB   United Kingdom
Hydrocortisone hydrogen succinate
   University Hospital of Wuerzburg
      2011   -   EUCTR2011-002687-25-DE   Germany
Hydrocortisone roussel
   CHU CAEN
      2007   Phase 2   EUCTR2007-005170-30-FR   France
Hydrocortisone sodium phosphate
   University Hospitals Bristol NHS Foundation Trust
      2014   -   EUCTR2012-001104-37-GB   United Kingdom
Hydrocortisone sodium succinate
   Haukeland University hospital
      2010   -   EUCTR2009-010917-61-SE   Sweden
Hydrocortisonum
   Haukeland University hospital
      2010   -   EUCTR2009-010917-61-SE   Sweden
Hydrokortison APL kapsel 2,5 MG
   Haukeland University hospital
      2010   -   EUCTR2009-010917-61-SE   Sweden
Isocaloric diet
   Oregon Health and Science University
      2000   -   NCT00688987   United States
Liquorice
   Haukeland University Hospital
      2008   -   NCT01271296   Norway
Mabthera
   Newcastle upon Tyne Hospitals NHS Trust
      2008   Phase 4   EUCTR2007-003062-18-GB   United Kingdom
Mabthera infusion
   Newcastle upon Tyne Hospitals NHS Foundation Trust
      2012   Phase 2   EUCTR2012-001682-33-GB   United Kingdom
Methylprednisolone
   Newcastle upon Tyne Hospitals NHS Foundation Trust
      2012   Phase 2   EUCTR2012-001682-33-GB   United Kingdom
Rituximab
   Newcastle upon Tyne Hospitals NHS Foundation Trust
      2012   Phase 2   EUCTR2012-001682-33-GB   United Kingdom
SOLU-cortef
   Haukeland University Hospital
      2014   Phase 1/Phase 2   NCT02096510   Norway
      2013   Phase 2   EUCTR2013-004189-33-NO   Norway
      2010   Phase 2/Phase 3   NCT01063569   Norway;Sweden
   Haukeland University hospital
      2010   -   EUCTR2009-010917-61-SE   Sweden
   The London Clinic
      2015   Phase 4   EUCTR2015-001090-40-GB   United Kingdom
SOLU-cortef 100 MG injection
   The London Clinic
      2022   Phase 4   NCT05350020   United Kingdom
SOLU-medrone
   Newcastle upon Tyne Hospitals NHS Foundation Trust
      2012   Phase 2   EUCTR2012-001682-33-GB   United Kingdom
   Newcastle upon Tyne Hospitals NHS Trust
      2008   Phase 4   EUCTR2007-003062-18-GB   United Kingdom
Synacthen depot
   Newcastle upon Tyne Hospitals NHS Foundation Trust
      2012   Phase 2   EUCTR2012-001682-33-GB   United Kingdom
      2010   -   EUCTR2009-018074-56-GB   United Kingdom
Tetracosactide acetate
   Newcastle upon Tyne Hospitals NHS Foundation Trust
      2012   Phase 2   EUCTR2012-001682-33-GB   United Kingdom